Incyte (INCY) Income After Tax (2009 - 2026)
Incyte's Income After Tax was -$784.8 million in Q3 2026, compared with $424.17 million a year earlier.
Powered by 
Analysis
Incyte (INCY) Income After Tax (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Incyte's Income After Tax was $403.41 million through Sep 30, 2026, down 66.1% year-over-year; for FY2025, it was $1.29 billion.
- In earlier years, Income After Tax was $32.62 million in FY2024 (-94.5%), $597.6 million in FY2023 (+75.4%), $340.66 million in FY2022 (-64.1%) and $948.58 million in FY2021.
- The Q3 2026 figure marks the lowest quarterly Income After Tax in data going back to Q1 2010.
- Compared with a year earlier, Income After Tax was higher in five of the last six quarters, with growth averaging 79.5%.
- The best year-over-year quarter for Income After Tax over five years was Q1 2024 (growth of 681.2%); the worst was Q4 2022 (a decline of 95.0%).
- Per Business Quant data, INCY's Income After Tax in the three quarters before Q3 2026 was $585.61 million (Q2 2026), $303.33 million (Q1 2026) and $299.28 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | -784.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -784.80 Mn |
| Jun 30, 2026 | 585.61 Mn |
| Mar 31, 2026 | 303.33 Mn |
| Dec 31, 2025 | 299.28 Mn |
| Sep 30, 2025 | 424.17 Mn |
| Jun 30, 2025 | 405.00 Mn |
| Mar 31, 2025 | 158.20 Mn |
| Dec 31, 2024 | 201.21 Mn |
| Sep 30, 2024 | 106.46 Mn |
| Jun 30, 2024 | -444.60 Mn |
| Mar 31, 2024 | 169.55 Mn |
| Dec 31, 2023 | 201.08 Mn |
| Sep 30, 2023 | 171.27 Mn |
| Jun 30, 2023 | 203.55 Mn |
| Mar 31, 2023 | 21.70 Mn |
| Dec 31, 2022 | 28.46 Mn |
| Sep 30, 2022 | 112.78 Mn |
| Jun 30, 2022 | 161.43 Mn |
| Mar 31, 2022 | 37.99 Mn |
| Dec 31, 2021 | 563.86 Mn |
API Access
Incyte Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();